Jonathan P. Jackson

1.1k total citations
21 papers, 821 citations indexed

About

Jonathan P. Jackson is a scholar working on Oncology, Pharmacology and Epidemiology. According to data from OpenAlex, Jonathan P. Jackson has authored 21 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pharmacology and 8 papers in Epidemiology. Recurrent topics in Jonathan P. Jackson's work include Drug Transport and Resistance Mechanisms (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Jonathan P. Jackson is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug-Induced Hepatotoxicity and Protection (7 papers). Jonathan P. Jackson collaborates with scholars based in United States, Czechia and Japan. Jonathan P. Jackson's co-authors include Craig D. Fisher, Stephen Ferguson, Lisa M. Augustine, Andrew J. Lickteig, Nathan J. Cherrington, James Ranger‐Moore, Kenneth R. Brouwer, Nathan J. Cherrington, Kimberly Freeman and Joyce A. Goldstein and has published in prestigious journals such as Molecular Pharmacology, Toxicological Sciences and Drug Metabolism and Disposition.

In The Last Decade

Jonathan P. Jackson

21 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan P. Jackson United States 15 333 302 279 233 144 21 821
Andrew J. Lickteig United States 15 439 1.3× 227 0.8× 391 1.4× 239 1.0× 154 1.1× 25 901
Lisa M. Augustine United States 14 383 1.2× 326 1.1× 469 1.7× 332 1.4× 141 1.0× 17 1.1k
Nelson Varela Chile 17 464 1.4× 236 0.8× 157 0.6× 535 2.3× 109 0.8× 59 1.3k
Xiaobo Yang China 18 203 0.6× 235 0.8× 262 0.9× 310 1.3× 71 0.5× 31 836
Dagmara Mohuczy United States 12 213 0.6× 203 0.7× 125 0.4× 303 1.3× 153 1.1× 17 913
Hemantkumar Chavan United States 16 384 1.2× 177 0.6× 149 0.5× 368 1.6× 109 0.8× 23 936
Douglas M. Heuman United States 10 228 0.7× 418 1.4× 503 1.8× 226 1.0× 179 1.2× 15 1.0k
April D. Lake United States 17 870 2.6× 160 0.5× 365 1.3× 429 1.8× 266 1.8× 23 1.3k
Aida Ortega‐Alonso Spain 14 222 0.7× 446 1.5× 113 0.4× 147 0.6× 141 1.0× 27 781
Xiulong Song United States 18 131 0.4× 218 0.7× 407 1.5× 259 1.1× 56 0.4× 25 865

Countries citing papers authored by Jonathan P. Jackson

Since Specialization
Citations

This map shows the geographic impact of Jonathan P. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Jackson more than expected).

Fields of papers citing papers by Jonathan P. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Jackson. The network helps show where Jonathan P. Jackson may publish in the future.

Co-authorship network of co-authors of Jonathan P. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan P. Jackson. A scholar is included among the top collaborators of Jonathan P. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan P. Jackson. Jonathan P. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roe, Amy L., Rachel Wilcox, Lijuan Li, et al.. (2019). An Evaluation of Potential Inhibition of CYP3A4/5 and CYP2C9 Enzymatic Activity by Boswellia serrata Extract. 5(1). 34–46. 8 indexed citations
2.
Jackson, Jonathan P. & Kenneth R. Brouwer. (2019). The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity. Methods in molecular biology. 1981. 75–85. 4 indexed citations
3.
Sissung, Tristan M., Ralph J. Hauke, Cody J. Peer, et al.. (2019). Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters. Molecular Pharmacology. 96(2). 158–167. 24 indexed citations
4.
Jackson, Jonathan P., Kimberly Freeman, Robert L. St. Claire, Chris Black, & Kenneth R. Brouwer. (2018). Cholestatic Drug Induced Liver Injury: A Function of Bile Salt Export Pump Inhibition and Farnesoid X Receptor Antagonism. 4(3). 265–279. 19 indexed citations
5.
Jackson, Jonathan P., et al.. (2018). A structural activity relationship strategy to mitigate cholestatic hepatoxicity liabilities utilizing the C-DILI™ assay. Drug Metabolism and Pharmacokinetics. 33(1). S72–S72. 1 indexed citations
6.
Jackson, Jonathan P., et al.. (2017). Prediction of Clinically Relevant Herb-Drug Clearance Interactions Using Sandwich-Cultured Human Hepatocytes: Schisandra spp. Case Study. Drug Metabolism and Disposition. 45(9). 1019–1026. 17 indexed citations
7.
Zhang, Yuanyuan, Jonathan P. Jackson, Robert L. St. Claire, et al.. (2017). Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich‐cultured human hepatocytes. Pharmacology Research & Perspectives. 5(4). 42 indexed citations
8.
Mosedale, Merrie, Donald Button, Jonathan P. Jackson, et al.. (2017). Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa). Toxicological Sciences. 161(2). 401–411. 14 indexed citations
9.
Zhang, Yuanyuan, et al.. (2017). Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models. Pharmacology Research & Perspectives. 5(6). 24 indexed citations
10.
Jackson, Jonathan P., et al.. (2016). Basolateral Efflux Transporters: A Potentially Important Pathway for the Prevention of Cholestatic Hepatotoxicity. 2(4). 207–216. 25 indexed citations
11.
Jackson, Jonathan P., et al.. (2016). Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures. Drug Metabolism and Disposition. 44(9). 1463–1479. 45 indexed citations
12.
Canet, Mark J., Matthew D. Merrell, Bryan Harder, et al.. (2014). Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene. Drug Metabolism and Disposition. 43(1). 93–99. 19 indexed citations
13.
Lake, April D., Petr Novák, Craig D. Fisher, et al.. (2011). Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 39(10). 1954–1960. 124 indexed citations
14.
Witek, Rachel M., et al.. (2011). Co-culture of Cryopreserved Primary Rat and Human Kupffer Cells and Hepatocytes to Study APAP Cytotoxicity. 1 indexed citations
15.
Fisher, Craig D., Andrew J. Lickteig, Lisa M. Augustine, et al.. (2009). Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 37(10). 2087–2094. 268 indexed citations
16.
Fisher, Craig D., Jonathan P. Jackson, Andrew J. Lickteig, Lisa M. Augustine, & Nathan J. Cherrington. (2008). Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. Archives of Toxicology. 82(12). 959–964. 45 indexed citations
17.
Jackson, Jonathan P., et al.. (2008). In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes. Chemico-Biological Interactions. 179(2-3). 263–272. 13 indexed citations
18.
Merrell, Matthew D., Jonathan P. Jackson, Lisa M. Augustine, et al.. (2008). The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor. Drug Metabolism and Disposition. 36(8). 1716–1721. 40 indexed citations
19.
Jackson, Jonathan P., Stephen Ferguson, Masahiko Negishi, & Joyce A. Goldstein. (2006). Phenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane Receptor. Drug Metabolism and Disposition. 34(12). 2003–2010. 35 indexed citations
20.
Jackson, Jonathan P., Stephen Ferguson, Rick Moore, Masahiko Negishi, & Joyce A. Goldstein. (2004). The Constitutive Active/Androstane Receptor Regulates Phenytoin Induction of Cyp2c29. Molecular Pharmacology. 65(6). 1397–1404. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Lickteig Breakdown of academic impact, for papers by Lisa M. Augustine Breakdown of academic impact, for papers by Nelson Varela Breakdown of academic impact, for papers by Xiaobo Yang Breakdown of academic impact, for papers by Dagmara Mohuczy Breakdown of academic impact, for papers by Hemantkumar Chavan Breakdown of academic impact, for papers by Douglas M. Heuman Breakdown of academic impact, for papers by April D. Lake Breakdown of academic impact, for papers by Aida Ortega‐Alonso Breakdown of academic impact, for papers by Xiulong Song
Rankless by CCL
2026